(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SANRO HEALTH

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

SANRO HEALTH

ST13

US500000079352262

Class

9, 42

Filing

79352262

Registration

7341629

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

11/02/2024

Trademark type

Word

Nice classes

9, 42

Filing date

07/08/2022

Registration date

04/02/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/02/2024

Last transaction

04/02/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

AU

Examiner

VAGHANI, MAYUR

Law office

N60

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Sanro Health Holdings Pty Ltd

Representatives

Andrew S. Ehard

Technical classification

Nice Classes

Class 9Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Downloadable computer software for use in the encryption and decryption of digital files; downloadable computer software for computer system and application developmentdeployment and management; downloadable computer software for use in the exchange of data between healthcare provider software and hardware and cloud-based software; downloadable computer software for the extraction of data from healthcare software and hardware; downloadable computer software using artificial intelligence for use in software development; downloadable computer software for use by health care providersresearcherspharmaceutical companies or patients to improve efficiencies in the conducting of clinical trials; software as a medical device (samd)downloadablefor diagnosingtreating or monitoring of ophthalmicimmunologicrheumatologicurologiccardiovascularneurologic or genetic disease

Class 42

Consulting services in the field of software as a service (SaaS); software as a service (SaaS) services featuring artificial intelligence software for extracting and generating datadatabase managementanalysis of data and information for use in the fields of health care and pharmaceutical consultancy and research; software as a service (SaaS) serviceshosting software for use by others for database managementanalysis of data and information in the fields of clinical trialspharmaceutical and medical research; computer software development; installation of computer software; online provision of non-downloadable web-based software that enables users to improve efficiencies in the conducting of clinical trials; conducting research and clinical trials for others relating to medical devices or pharmaceuticals in the fields of ophthalmologyimmunologyrheumatologyurologycardiovascular medicineneurology or genetics; medical and scientific researchconducting clinical trials for others; pharmaceutical research and development; consulting services in the field of pharmaceutical research and development; pharmaceutical product evaluation being services for assessing the efficiency and safety of pharmaceuticals; consultancy pertaining to pharmacology; advisory services relating to product quality testing; providing medical research information in the fields of pharmaceuticals and clinical trials; consulting services for others in the fields of designplanningimplementation project management of scientific research and clinical trials; research for development of new products being pharmaceuticals; database design and development; providing virtual computer systems and virtual computer environments through cloud computing; scientific research consulting in the fields of ophthalmologyimmunologyrheumatologyurologycardiovascular medicineneurology or genetics; providing quality assurance consultancy services in the fields of medical research and clinical trials; consultancy in the field of artificial intelligence technology; research in the field of artificial intelligence technology; information technology (IT) consulting services; testinganalysis and evaluation of the goods and services of others to determine conformity with certification standards

Publications

History of USPTO decisions and trademark events.

29 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

11/02/2024

FICS

FINAL DISPOSITION NOTICE SENT TO IB

10/16/2024

FIMP

FINAL DISPOSITION PROCESSED

10/16/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

07/03/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/02/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

04/02/2024

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

04/01/2024

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

03/13/2024

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

03/13/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/16/2024

PUBO

PUBLISHED FOR OPPOSITION

01/16/2024

GPNX

NOTIFICATION PROCESSED BY IB

01/13/2024

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

12/27/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

12/27/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/27/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/08/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/07/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/07/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/07/2023

RFNP

REFUSAL PROCESSED BY IB

07/04/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

06/09/2023

RFRR

REFUSAL PROCESSED BY MPU

06/08/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

04/28/2023

CNRT

NON-FINAL ACTION WRITTEN

04/27/2023

DOCK

ASSIGNED TO EXAMINER

04/24/2023

MAFR

APPLICATION FILING RECEIPT MAILED

10/25/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/21/2022

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

10/20/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

10/13/2022

Continuous trademark protection

Get notified about every new filing that threatens SANRO HEALTH or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.